• Accessibility statement
  • Homepage
  • Sitemap
  • Search
  • Contact
  • Print
Boehringer-Ingelheim Logo
Value through Innovation

Help

jump to main navigationjump to content
  • Home
  • Contact
  • Site Map

main navigation

jump to contentto meta navigation
  • News Centre
  • Corporate Profile
  • Corporate Responsibility
  • Global Activities
  • Research & Development
  • Clinical Trials
  • Products
  • Contract Manufacturing
  • Careers
World Cancer Day 2012

page content

jump to main navigationto meta navigation

Oncology and white room

No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player
  • Discover oncology website
  • Discover the white room

Our Global Activities

  • Our Countries A-Z
  • Albania
  • Argentina
  • Armenia
  • Austria
  • Australia
  • Azerbaijan
  • Bahrain
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Estonia
  • Ethiopia
  • Finland
  • France
  • Georgia
  • Germany
  • Germany Headquarters
  • Greece
  • Ghana
  • Hong Kong
  • Hungary
  • India
  • Indonesia
  • Iraq
  • Irland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kirghizia
  • Kuweit
  • Latvia
  • Lebanon
  • Libya
  • Lithuania
  • Macedonia
  • Malawi
  • Malaysia
  • Malta
  • Mauritius
  • Mexico
  • Moldavia
  • Mongolia
  • Montenegro
  • The Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Peru
  • The Philippines
  • Poland
  • Portugal
  • Quatar
  • Romania
  • Russia
  • Saudi Arabia
  • Seychelles
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • Somalia
  • South Africa
  • South Korea
  • Spain
  • Sudan
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Turkey
  • Turkmenistan
  • USA
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • Uruguay
  • Uzbekistan
  • Venezuela
  • Vietnam
  • Yemen
for US residents

Latest Press Releases

03.02.2012 Boehringer Ingelheim, GWT and the TU Dresden sign diabetes research collaboration
31.01.2012 FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes -

For Non-U.S. and Non-UK Media

26.01.2012 Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply
26.01.2012 Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib* -

FOR NON-US MEDIA ONLY

14.12.2011 Boehringer Ingelheim significantly expands its supply center for China
Further press releases

Partnership with Ashoka

Making more health
Ashoka/Changemakers

Drug discovery process

From discovery to a marketable drug is a long road, always led by curiosity
See further details

Diabetes Initiative

Diabetes Initiative
More about the initiative
back to top

Further Media Channels

  • Mobile Devices
  • RSS Feed
  • Follow us on Facebook
  • Follow us on Twitter
  • Follow us on YouTube
  • Follow us on flickr

Top Links

Take-away-info Annual report Financial highlights Licensing & Partnering Careers - experienced Indication areas Stroke Prevention Consumer Health Care Biopharmaceuticals Animal Health Research Areas Contact
© 2010 - 2012 Boehringer Ingelheim GmbH All rights reserved
  • Print Page
  • Recommend
  • Accessibility Statement
  • Terms of use
  • Imprint
  • RSS Feed